
UltraGreen announces US FDA orphan drug designation for IC-GREEN® in hepatocellular carcinoma
UltraGreen.ai Limited, together with its Diagnostic Green business, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to IC-GREEN®
(indocyanine green for injection), for use as a diagnostic for the management of hepatocellular carcinoma (HCC).










